Radiopharm Theranostics RADX Ratios (2023-2026)

NASDAQ RADX
$1.44 -0.18 (-11.11%)
As of: Oct 1, 2026 · 10:36 AM EDT
Reported Financials

Radiopharm Theranostics Quarterly Ratios

Periods 5 quarters
Latest Jun 2026

Radiopharm Theranostics ratios data for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2023 Jun2024 Dec2024 Jun2025 Jun2026
Efficiency
Assets AverageAssets Avg. 46.46M46.50M0.49M
Equity AverageEquity Avg. 22.88M26.09M26.14M0.22M
Invested CapitalInvested Cap. 0.40M81.55M0.48M0.34M
Leverage & Solvency
Interest Coverage RatioInterest Cover -400.59-73.43-584.59-505.21
Debt Ratio 0.460.320.370.43
Times Interest Earned -400.59-73.43-584.59-505.21
Return Ratios
Return on Capital Employed [ROCE]ROCE -36,591.98%
Return on Invested Capital [ROIC]ROIC -31,686.19%
Return on Assets [ROA]ROA -26,756.88%
Return on Equity [ROE]ROE -60,595.37%

Radiopharm Theranostics Ratios API

Pull Radiopharm Theranostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RADX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY